Amwill Health Care Ltd - Stock Valuation and Financial Performance

Amwill Health Care Limited was originally incorporated on August 21, 2017 under the name ‘Amwill Health Care Private Limited’, pursuant to a certificate of incorporation dated August 22, 2017 issued by the Deputy Registrar of Companies, Karnataka at Bangalore. Further, the company was converted into a public limited company pursuant to a resolution passed by its Board of Directors in their meeting held on December 28, 2023 and by the Shareholders in an Extraordinary General Meeting held on December 29, 2023 and a fresh certificate of incorporation dated January 25, 2024 was issued by the Registrar of Companies, Karnataka at Bangalore. Consequent to the conversion of the company, the name of the company was changed to ‘Amwill Health Care Limited’.

Amwill Healthcare is a derma-cosmetic development company, associated with contract manufacturers, distributor and third-party product development agencies, which has enabled it in developing capabilities, in manufacturing, packaging and distribution. The core focus of the company is on development of problem solving dermatological, cosmeceutical and aesthetical products, and therefore to direct all its efforts towards product formulation and development, it has outsourced key functions such as manufacturing, prototype development and distribution to third parties, for effective management and execution. In line of the aforementioned business strategy, it has presently created a business presence in Karnataka, Andhra Pradesh and Telangana, wherein it focuses on deepening its presence in the regions it operates in, before venturing into new markets, thereby enabling it to establish a customer base in such states. This enables the target customers to identify with its product portfolio and aids its understanding of the market segment and the customer demand preference.

The product portfolio of the company is divided into two categories, namely, (i) development and contract manufacturing of generic dermatological solutions; and (ii) developing and formulating solutions to specific dermatological problem. Majority of the products marketed by it, were developed by its Promoter and Managing Director, Anand Gandhi, in the capacity of a sole proprietor of M/s. Amwill Healthcare. Since incorporation, the company has developed seven new products, namely proputor tabs, XL hydra cream, ozederm cream, PD-pill 10 tablets, XL aqua moisturising lotion, ultra kromaglo effervescent tablets and depimed ultra cream. Out of these products, the company did not receive a positive response for PD -pill 10 tablets, proputor tabs and ozederm cream and therefore has discontinued former two products.

Since inception, the company’s focus has been on developing formulations which offer solutions to various dermatological disorders. Owing to the longstanding experience of its promoters in the dermatological industry, its Promoters have remained in constant touch with various dermatologists and medical professionals. Due to its ongoing professional relationship with such dermatologists and medical professionals, it has been able to leverage their experience, while developing its products. The company during the ordinary course of business, seeks advice from various dermatologists and medical professionals, to develop solutions for various dermatological problems. The dermatologists, assist and advise the company in identifying the gaps in skincare or cosmetic market, through their experience. The company based on such suggestions identifies a dermatological problem and develops a formulation of a derma-cosmetic suitable for addressing the designated problem.

Business area of the company 

The company is engaged in the business of dealing in pharma products.

Products of the company 

• Anti acne
• Dry skin
• Anti-ageing
• Anti-fungal
• Anti-histaminics
• Anti- perspirant
• Skin lightening
• Specialized hair care
• Antioxidants
• Anti scar
• Peri orbital hyperpigmentation
• Vitilgo
• Sunscreen
• Steroid & keratolytics

Awards and Accreditations

• 2022: Indian Association of Dermatologists, Venereologists & Leprologists Karnataka Branch - IADVL issued a certificate to the company for recognising its service and contribution during the CUTICON KN 2022.
• 2022: Indian Association of Dermatologists, Venereologists & Leprologists Karnataka Branch - IADVL issued a certificate to the company for recognising its service and contribution during the CUTICON KN 2023.
• 2022: Indian Association of Dermatologists, Venereologists & Leprologists Karnataka Branch - IADVL issued a certificate to the company for recognising its efforts as an exhibitor during the CUTICON KN 2023.
• 2022: The company received a certificate of participation from ROOTS-V, a national conference and workshop on clinical dermatology.

History and milestones

• 2017: The company was incorporated on August 21, 2017 under the name ‘Amwill Health Care Private Limited’, pursuant to a certificate of incorporation dated August 22, 2017 issued by the Deputy Registrar of Companies, Karnataka at Bangalore.
• 2020: The company registered the first transaction of sale of cosmetic products
• 2021: The company launched a new product under the name ‘XL-HYDRA’, a face moisturizer.
• 2021: The company launched a new formulation in hair-care therapy under the name ‘Fin-XL Pro Gel’ in a gel based formulation.
• 2022: The company achieved a milestone turnover of more than Rs 2,500 lakh.
• 2023: The company achieved a milestone turnover of more than Rs 3,000.00 lakh.
• 2024: The company received a license under Food Safety and Standards Act, 2006, in the capacity of a distributor, retailer, wholesaler and relabeller of food or health supplements and nutraceuticals.